TY - JOUR
T1 - Considerations and alternative approaches to antibiotic prophylaxis for prostate biopsy
AU - Kim, Eric H.
AU - Andriole, Gerald L.
N1 - Publisher Copyright:
© The Canadian Journal of Urology™;
PY - 2020
Y1 - 2020
N2 - In this study of culture-specific antibiograms from six hospitals in the Philadelphia region, the authors compare American Urological Association (AUA) recommendations for prostate biopsy prophylaxis against the common urinary pathogens, E. coli, Klebsiella, and Proteus.1 The authors examine the sensitivity of these pathogens to the most commonly utilized antibiotics for biopsy prophylaxis, including fluoroquinolones (FQ), trimethoprim/ sulfamethoxazole (TMP/SMX), gentamicin, and ceftriaxone. The results are alarming, with E. coli resistance to FQ and TMP/SMX ranging from 20% to 32%; Klebsiella resistance to FQ and TMP/SMX ranging from 6% to 22%; Proteus resistance to FQ and TMP/SMX ranging from 10 to 32%.
AB - In this study of culture-specific antibiograms from six hospitals in the Philadelphia region, the authors compare American Urological Association (AUA) recommendations for prostate biopsy prophylaxis against the common urinary pathogens, E. coli, Klebsiella, and Proteus.1 The authors examine the sensitivity of these pathogens to the most commonly utilized antibiotics for biopsy prophylaxis, including fluoroquinolones (FQ), trimethoprim/ sulfamethoxazole (TMP/SMX), gentamicin, and ceftriaxone. The results are alarming, with E. coli resistance to FQ and TMP/SMX ranging from 20% to 32%; Klebsiella resistance to FQ and TMP/SMX ranging from 6% to 22%; Proteus resistance to FQ and TMP/SMX ranging from 10 to 32%.
UR - http://www.scopus.com/inward/record.url?scp=85079741142&partnerID=8YFLogxK
M3 - Article
C2 - 32065867
AN - SCOPUS:85079741142
SN - 1195-9479
VL - 27
SP - 10105
JO - Canadian Journal of Urology
JF - Canadian Journal of Urology
IS - 1
ER -